dc.creator | Fonseca D. | |
dc.creator | Leal-Pinto S.M. | |
dc.creator | Roa-Cordero M.V. | |
dc.creator | Vargas J.D. | |
dc.creator | Moreno-Moreno E.M. | |
dc.creator | Macías M.A. | |
dc.creator | Suescun L. | |
dc.creator | Muñoz-Castro Á. | |
dc.creator | Hurtado J.J. | |
dc.date.accessioned | 2020-09-02T22:17:55Z | |
dc.date.accessioned | 2022-11-08T20:23:58Z | |
dc.date.available | 2020-09-02T22:17:55Z | |
dc.date.available | 2022-11-08T20:23:58Z | |
dc.date.created | 2020-09-02T22:17:55Z | |
dc.date.issued | 2019 | |
dc.identifier | 20, 13, - | |
dc.identifier | 16616596 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4498 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145070 | |
dc.language | en | |
dc.publisher | MDPI AG | |
dc.subject | Antifungal activity | |
dc.subject | Cobalt(II) complexes | |
dc.subject | Crystal structure | |
dc.subject | Cytotoxicity | |
dc.subject | Dimorphic switch | |
dc.subject | Pyrazole and dinitrobenzoate ligands | |
dc.subject | Trypanosoma cruzi | |
dc.subject | 2,6 bis(3,5 dimethyl 1 pyrazolyl)pyridine | |
dc.subject | 2,6 bis(3,5 dimethyl 4 nitro1pyrazolyl)pyridine | |
dc.subject | 3,5 bis(3,5 dimethyl 4 nitropyrazol 1 ylmethyl)toluene | |
dc.subject | benznidazole | |
dc.subject | bis(3,5 dimethyl 1 pyrazolyl)methane | |
dc.subject | bis(3,5 dimethyl 4 nitro 1 pyrazolyl)methane | |
dc.subject | bis(dinitrobenzoate o,o’) | |
dc.subject | cobalt complex | |
dc.subject | dinitrobenzoate | |
dc.subject | dinitrobenzoate[2,6 bis(3,5 dimethyl 4 nitro pyrazol 1 ylmethyl)pyridine] | |
dc.subject | dinitrobenzoate[2,6 bis(3,5 dimethylpyrazol 1 ylmethyl)pyridine] | |
dc.subject | dinitrobenzoate[3,5 bis(3,5 dimethyl 4 nitro pyrazol 1 ylmethyl)toluene] | |
dc.subject | dinitrobenzoate[3,5 bis(3,5 dimethylpyrazol 1 ylmethyl)toluene] | |
dc.subject | dinitrobenzoate[bis(3,5 dimethyl 4 nitro pyrazol 1yl)methane] | |
dc.subject | dinitrobenzoate[bis(3,5 dimethylpyrazol 1 yl)methane] | |
dc.subject | itraconazole | |
dc.subject | nitrobenzoic acid derivative | |
dc.subject | pyrazole | |
dc.subject | unclassified drug | |
dc.subject | antiinfective agent | |
dc.subject | cobalt | |
dc.subject | coordination compound | |
dc.subject | ligand | |
dc.subject | nitrobenzene derivative | |
dc.subject | pyrazole derivative | |
dc.subject | animal cell | |
dc.subject | antibiotic sensitivity | |
dc.subject | antifungal activity | |
dc.subject | Article | |
dc.subject | bioassay | |
dc.subject | biological activity | |
dc.subject | broth dilution | |
dc.subject | Candida albicans | |
dc.subject | Candida tropicalis | |
dc.subject | carbon nuclear magnetic resonance | |
dc.subject | controlled study | |
dc.subject | crystal structure | |
dc.subject | crystallization | |
dc.subject | cytotoxicity | |
dc.subject | drug synthesis | |
dc.subject | electrospray | |
dc.subject | elemental analysis | |
dc.subject | Fourier transform infrared spectroscopy | |
dc.subject | fungus hyphae | |
dc.subject | gas chromatography | |
dc.subject | germ tube inhibition assay | |
dc.subject | growth inhibition | |
dc.subject | IC50 | |
dc.subject | infrared spectroscopy | |
dc.subject | mass spectrometry | |
dc.subject | melting point | |
dc.subject | minimum inhibitory concentration | |
dc.subject | MTT assay | |
dc.subject | nonhuman | |
dc.subject | Pichia kudriavzevii | |
dc.subject | proton nuclear magnetic resonance | |
dc.subject | Raman spectrometry | |
dc.subject | Trypanosoma cruzi | |
dc.subject | ultraviolet visible spectrophotometry | |
dc.subject | Vero cell line | |
dc.subject | X ray diffraction | |
dc.subject | animal | |
dc.subject | Candida albicans | |
dc.subject | cell survival | |
dc.subject | chemical structure | |
dc.subject | chemistry | |
dc.subject | Chlorocebus aethiops | |
dc.subject | drug effect | |
dc.subject | microbial sensitivity test | |
dc.subject | structure activity relation | |
dc.subject | synthesis | |
dc.subject | X ray crystallography | |
dc.subject | Animals | |
dc.subject | Anti-Bacterial Agents | |
dc.subject | Candida albicans | |
dc.subject | Cell Survival | |
dc.subject | Chlorocebus aethiops | |
dc.subject | Cobalt | |
dc.subject | Coordination Complexes | |
dc.subject | Crystallography, X-Ray | |
dc.subject | Dinitrobenzenes | |
dc.subject | Ligands | |
dc.subject | Microbial Sensitivity Tests | |
dc.subject | Molecular Structure | |
dc.subject | Pyrazoles | |
dc.subject | Structure-Activity Relationship | |
dc.subject | Vero Cells | |
dc.title | Inhibition of C. albicans dimorphic switch by cobalt(II) complexes with ligands derived from pyrazoles and dinitrobenzoate: Synthesis, characterization and biological activity | |
dc.type | Article | |